Get the latest market trends in your inbox
Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul
Tampa-St. Petersburg news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg
Sec. Mattis listens to President Trump during a cabinet meeting. Photo by Saul Loeb/Getty Images.
U.S. Defense Secretary James Mattis is declining to comment on the alleged $700 million fraud at Theranos, much of which occurred while he sat on the blood-testing company's board of directors.
- Mattis joined the Theranos board after retiring from the military in 2013, and left after being nominated by President Trump.
- Statement from Mattis spokeswoman Dana White, who declined to elaborate: “Secretary Mattis was struck by the promise of technology and was looking for any technology solution to save lives on the battlefield. He resigned his position on the Theranos board on Dec. 16th prior to his confirmation.”